BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Andrew Hirsch, BIND’s chief operating officer and chief financial officer, will present at the Cowen & Co. 35th Annual Healthcare Conference in Boston on Tuesday, March 3, 2015 at 10:40 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
